FDA Adverse Event Other Summary report: N

ADVIA CENTAUR HBSAG ASSAY

MDR report key: 1593662 · Received February 1, 2010

Report

Report Number
1219913-2010-00013
Event Type
Other
Date Received
February 1, 2010
Date of Event
January 2, 2010
Report Date
January 21, 2010
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
LOM
PMA / PMN Number
P030049
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR (B)(6) RESULT WITH OTHER METHODS IS UNKNOWN. THE INSTRUCTIONS FOR USE (IFU) LIMITATION SECTION STATES: "IT IS RECOGNIZED THAT THE CURRENT METHODS FOR THE DETECTION OF (B)(6) SURFACE ANTIGEN MAY NOT DETECT ALL POTENTIALLY INFECTED INDIVIDUALS. A NONREACTIVE TEST RESULT DOES NOT EXCLUDE THE POSSIBILITY OF EXPOSURE TO OR INFECTION WITH (B)(6). A NONREACTIVE TEST RESULT IN INDIVIDUALS WITH PRIOR EXPOSURE TO (B)(6) MAY BE DUE TO ANTIGEN LEVELS BELOW THE DETECTION LIMIT OF THIS ASSAY OR LACK OF ANTIGEN REACTIVITY TO THE ANTIBODIES IN THIS ASSAY." THE CUSTOMER DECLINED SERVICE - NO FURTHER ACTION TAKEN.

Description of Event or Problem · 1

A NEGATIVE ADVIA CENTAUR XP (B)(6) RESULT WAS OBTAINED FOR A PATIENT SAMPLE. THE NEGATIVE RESULT DID NOT MATCH THE POSITIVE RESULT OBTAINED BY ANOTHER METHOD. THE PHYSICIAN QUESTIONED THE NEGATIVE RESULT. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT (B)(6) RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR HBSAG ASSAY HBS IMMUNOASSAY LOM SIEMENS HEALTHCARE DIAGNOSTICS INC. NA 145

Patients

Seq Age Sex Outcome Treatment
1